VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.73K shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-02-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | 0.00 shares 10-K · filed 2025-12-17 |
| 2025-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | 2.73K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 0.00 shares 10-Q · filed 2025-02-13 | |
| 2024-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | 2.73K shares 10-K · filed 2024-12-16 |
| 2024-06-30 | 2.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | |
| 2018-12-31 | 0.00 shares 10-Q · filed 2020-02-12 | |
| 2016-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | 0.00 shares 10-K · filed 2016-12-12 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-07-28 | 0.00 shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-04-28 | 0.00 shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-12-31 | 0.00 shares 10-Q · filed 2016-02-02 | 0.00 shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | 0.00 shares 10-K · filed 2016-12-12 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2016-07-28 | 30.00K shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-04-28 | 60.00K shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | 0.00 shares 10-Q · filed 2016-02-02 | 60.00K shares derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | 30.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | 60.00K shares 10-K · filed 2016-12-12 |
| 2014-06-30 | 30.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | 30.00K shares derived: sum of 4 quarters · filed 2015-12-02 |
| 2014-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30 | |
| 2013-12-31 | 0.00 shares 10-Q · filed 2015-02-03 | |
| 2013-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | 36.25K shares 10-K · filed 2015-12-02 |
| 2012-09-30 | 1.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | 1.56M shares 10-K · filed 2014-12-02 |
| 2012-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | |
| 2012-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | |
| 2011-12-31 | 193.75K shares 10-Q · filed 2013-01-30 | |
| 2010-09-30 | -435.00K shares 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |